Literature DB >> 19664628

Impaired immune functions of monocytes and macrophages in Whipple's disease.

Verena Moos1, Carsten Schmidt, Anika Geelhaar, Désirée Kunkel, Kristina Allers, Katina Schinnerling, Christoph Loddenkemper, Florence Fenollar, Annette Moter, Didier Raoult, Ralf Ignatius, Thomas Schneider.   

Abstract

BACKGROUND & AIMS: Whipple's disease is a chronic multisystemic infection caused by Tropheryma whipplei. Host factors likely predispose for the establishment of an infection, and macrophages seem to be involved in the pathogenesis of Whipple's disease. However, macrophage activation in Whipple's disease has not been studied systematically so far.
METHODS: Samples from 145 Whipple's disease patients and 166 control subjects were investigated. We characterized duodenal macrophages and lymphocytes immunohistochemically and peripheral monocytes by flow cytometry and quantified mucosal and systemic cytokines and chemokines indicative for macrophage activation. In addition, we determined duodenal nitrite production and oxidative burst induced by T whipplei and by other bacteria.
RESULTS: Reduced numbers of duodenal lymphocytes, increased numbers of CD163(+) and stabilin-1(+), reduced numbers of inducible nitric synthase+ duodenal macrophages, and increased percentages of CD163(+) peripheral monocytes indicated a lack of inflammation and a M2/alternatively activated macrophage phenotype in Whipple's disease. Incubation with T whipplei in vitro enhanced the expression of CD163 on monocytes from Whipple's disease patients but not from control subjects. Chemokines and cytokines associated with M2/alternative macrophage activation were elevated in the duodenum and the peripheral blood from Whipple's disease patients. Functionally, Whipple's disease patients showed a reduced duodenal nitrite production and reduced oxidative burst upon incubation with T whipplei compared with healthy subjects.
CONCLUSIONS: The lack of excessive local inflammation and alternative activation of macrophages, triggered in part by the agent T whipplei itself, may explain the hallmark of Whipple's disease: invasion of the intestinal mucosa with macrophages incompetent to degrade T whipplei. Copyright 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19664628     DOI: 10.1053/j.gastro.2009.07.066

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  35 in total

1.  Whipple's Disease: Diagnostic Value of rpoB Gene PCR from Peripheral Blood Mononuclear Cells.

Authors:  Kathleen Weigt; Alexandra Wiessner; Annette Moter; Florence Fenollar; Didier Raoult; Kristina Allers; Thomas Schneider; Verena Moos
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

Review 2.  Whipple's disease.

Authors:  Federico Biagi; Lucia Trotta; Gino R Corazza
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

3.  Cytokine genetic profile in Whipple's disease.

Authors:  F Biagi; C Badulli; G E Feurle; C Müller; V Moos; T Schneider; T Marth; J Mytilineos; F Garlaschelli; A Marchese; L Trotta; P I Bianchi; M Di Stefano; A L Cremaschi; A De Silvestri; L Salvaneschi; M Martinetti; G R Corazza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-31       Impact factor: 3.267

Review 4.  Metabolic Factors that Contribute to Lupus Pathogenesis.

Authors:  Wei Li; Ramya Sivakumar; Anton A Titov; Seung-Chul Choi; Laurence Morel
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

5.  Haemophilus ducreyi-induced interleukin-10 promotes a mixed M1 and M2 activation program in human macrophages.

Authors:  Wei Li; Barry P Katz; Stanley M Spinola
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

Review 6.  [Tropheryma whipplei infection. Colonization, self-limiting infection and Whipple's disease].

Authors:  V Moos; C Loddenkemper; T Schneider
Journal:  Pathologe       Date:  2011-09       Impact factor: 1.011

7.  Comparative analysis of the interaction of Helicobacter pylori with human dendritic cells, macrophages, and monocytes.

Authors:  Michael Fehlings; Lea Drobbe; Verena Moos; Pablo Renner Viveros; Jana Hagen; Macarena Beigier-Bompadre; Ervinna Pang; Elena Belogolova; Yuri Churin; Thomas Schneider; Thomas F Meyer; Toni Aebischer; Ralf Ignatius
Journal:  Infect Immun       Date:  2012-05-21       Impact factor: 3.441

Review 8.  Clinical Manifestations, Treatment, and Diagnosis of Tropheryma whipplei Infections.

Authors:  Ruben A V Dolmans; C H Edwin Boel; Miangela M Lacle; Johannes G Kusters
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

9.  Epidemiology of Whipple's Disease in the USA Between 2012 and 2017: A Population-Based National Study.

Authors:  Jamie Ann Elchert; Emad Mansoor; Mohannad Abou-Saleh; Gregory S Cooper
Journal:  Dig Dis Sci       Date:  2018-11-28       Impact factor: 3.199

10.  Evaluation of arginine metabolism for the analysis of M1/M2 macrophage activation in human clinical specimens.

Authors:  Anika Geelhaar-Karsch; Katina Schinnerling; Kristina Conrad; Julian Friebel; Kristina Allers; Thomas Schneider; Verena Moos
Journal:  Inflamm Res       Date:  2013-06-18       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.